BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0223-2026

Winder Laboratories, LLC · Winder, GA

Class III Ongoing 169 days on record

Lower impact — Class III recall โ€” product violates FDA labeling or manufacturing standards but is unlikely to cause adverse health consequences.

Product

Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01

Lot / code: Lot 1312405; Exp 09/28/2027

Quantity: 3,528 30 mL Bottles

Reason for recall

Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.

Recall record

Recall number
D-0223-2026
Classification
Class III
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
N/A
Distribution
U.S. Nationwide
Recall initiated
2025-11-26
Classified by FDA Center
2025-12-09
FDA published
2025-12-17
Recalling firm
Winder Laboratories, LLC
Firm location
Winder, GA

Drug identification

Brand name(s)
MORPHINE SULFATE
Generic name(s)
MORPHINE SULFATE
Manufacturer(s)
Winder Laboratories LLC
NDC(s)
75826-129, 75826-130, 75826-131
Route(s)
ORAL

Operational response

Class III recalls are unlikely to cause adverse health consequences but indicate a violation of FDA labeling or manufacturing standards. Pull from active dispensing per your operational policy.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls